Cover Image
Read Now

Intravesical botulinum toxin for adults with non-neurogenic bladder conditions a review of clinical effectiveness, cost-effectiveness and guidelines

This Rapid Response report aims to review the clinical and cost-effectiveness of botulinum toxin for the treatment of non-neurogenic bladder conditions. Guidelines associated with the use of botulinum toxin for patients with non-neurogenic bladder conditions will also be examined

Bibliographic Details
Main Authors: Ho, Chuong, Visintini, Sarah (Author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2018, March 2018
Edition:Version 1.0
Series:CADTH rapid response report: summary with critical appraisal
Subjects:
Canada
Cost-benefit Analysis
Cystitis, Interstitial / Drug Therapy
Treatment Outcome
Botulinum Toxins, Type A / Therapeutic Use
Urinary Bladder, Overactive / Drug Therapy
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:This Rapid Response report aims to review the clinical and cost-effectiveness of botulinum toxin for the treatment of non-neurogenic bladder conditions. Guidelines associated with the use of botulinum toxin for patients with non-neurogenic bladder conditions will also be examined
Physical Description:1 PDF file (32 pages)

Similar Items